COMT Val158Met, BDNF Val66Met, and OPRM1 Asn40Asp and methamphetamine dependence treatment response: preliminary investigation.
Keith G
KG
Heinzerling
James T
JT
McCracken
Aimee-Noelle
AN
Swanson
Lara A
LA
Ray
Steven J
SJ
Shoptaw
D000328:Adult; D000483:Alleles; D019969:Amphetamine-Related Disorders / Q000235:genetics* / Q000534:rehabilitation*; D001521:Behavior Therapy; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D002394:Catechol O-Methyltransferase / Q000235:genetics*; D000697:Central Nervous System Stimulants; D015928:Cognitive Behavioral Therapy; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008694:Methamphetamine; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D017450:Receptors, Opioid, mu / Q000235:genetics*; D015813:Substance Abuse Detection; D016896:Treatment Outcome; D055815:Young Adult
D019208:Brain-Derived Neurotrophic Factor; D000697:Central Nervous System Stimulants; C485764:OPRM1 protein, human; D017450:Receptors, Opioid, mu; D008694:Methamphetamine; D002394:Catechol O-Methyltransferase